Free Trial

Thrivent Financial for Lutherans Lowers Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Thrivent Financial for Lutherans lowered its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 4.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 239,695 shares of the company's stock after selling 11,779 shares during the period. Thrivent Financial for Lutherans owned 0.41% of Molina Healthcare worth $71,262,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in MOH. Innealta Capital LLC acquired a new position in shares of Molina Healthcare in the 2nd quarter valued at $36,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Molina Healthcare in the second quarter worth about $40,000. Principal Securities Inc. acquired a new stake in shares of Molina Healthcare during the fourth quarter worth about $42,000. AM Squared Ltd purchased a new stake in Molina Healthcare in the second quarter valued at approximately $59,000. Finally, Mather Group LLC. acquired a new position in Molina Healthcare in the 1st quarter worth approximately $123,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Molina Healthcare

In related news, CAO Maurice Hebert sold 393 shares of the company's stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the sale, the chief accounting officer now owns 9,473 shares of the company's stock, valued at approximately $3,282,583.96. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company's stock, valued at approximately $6,114,260.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.


Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Stephens reissued an "equal weight" rating and set a $320.00 target price on shares of Molina Healthcare in a report on Thursday, July 25th. Robert W. Baird assumed coverage on Molina Healthcare in a report on Thursday, May 30th. They set an "outperform" rating and a $405.00 target price on the stock. Cantor Fitzgerald reissued an "overweight" rating and issued a $406.00 price target on shares of Molina Healthcare in a report on Tuesday, September 10th. Wells Fargo & Company raised their price objective on shares of Molina Healthcare from $315.00 to $360.00 and gave the stock an "equal weight" rating in a research note on Monday, August 5th. Finally, Truist Financial cut their target price on shares of Molina Healthcare from $440.00 to $400.00 and set a "buy" rating for the company in a report on Monday, July 15th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Molina Healthcare has an average rating of "Hold" and a consensus price target of $378.00.

Check Out Our Latest Research Report on Molina Healthcare

Molina Healthcare Price Performance

MOH traded up $1.51 during midday trading on Friday, hitting $351.42. 588,217 shares of the company traded hands, compared to its average volume of 496,573. The business has a 50 day simple moving average of $335.60 and a two-hundred day simple moving average of $343.15. Molina Healthcare, Inc. has a 52-week low of $282.96 and a 52-week high of $423.92. The company has a market capitalization of $20.59 billion, a price-to-earnings ratio of 19.07, a PEG ratio of 1.20 and a beta of 0.57. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, beating analysts' consensus estimates of $5.73 by $0.13. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The business had revenue of $9.88 billion during the quarter, compared to analysts' expectations of $9.75 billion. During the same quarter in the prior year, the firm earned $5.65 earnings per share. The business's revenue was up 18.7% compared to the same quarter last year. On average, equities analysts forecast that Molina Healthcare, Inc. will post 23.5 earnings per share for the current fiscal year.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

See Also

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

→ Proof the Election is Rigged??? (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Molina Healthcare right now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Stocks Members of Congress are Buying Ahead of the Election
Fed Walking a Tightrope with Rate Cuts
Is Palantir Heading for a $50 Price Target?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines